The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Respiratory Diagnostics Market Research Report 2024
Synopsis
The global Respiratory Diagnostics market was valued at US$ 5369.9 million in 2023 and is anticipated to reach US$ 7350.7 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Diagnostics.
Report Scope
The Respiratory Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Philips Healthcare
Becton, Dickinson
Abbott Laboratories
Thermo Fisher Scientific
Abbott
Segment by Type
Instruments and Devices
Assays and Reagents
Services and Software
Segment by Application
Hospital/Clinical Laboratories
Physician Offices
Reference Laboratories
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Respiratory Diagnostics market was valued at US$ 5369.9 million in 2023 and is anticipated to reach US$ 7350.7 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Diagnostics.
Report Scope
The Respiratory Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Philips Healthcare
Becton, Dickinson
Abbott Laboratories
Thermo Fisher Scientific
Abbott
Segment by Type
Instruments and Devices
Assays and Reagents
Services and Software
Segment by Application
Hospital/Clinical Laboratories
Physician Offices
Reference Laboratories
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments and Devices
1.2.3 Assays and Reagents
1.2.4 Services and Software
1.3 Market by Application
1.3.1 Global Respiratory Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital/Clinical Laboratories
1.3.3 Physician Offices
1.3.4 Reference Laboratories
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Diagnostics Market Perspective (2019-2030)
2.2 Respiratory Diagnostics Growth Trends by Region
2.2.1 Global Respiratory Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Respiratory Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Respiratory Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Respiratory Diagnostics Market Dynamics
2.3.1 Respiratory Diagnostics Industry Trends
2.3.2 Respiratory Diagnostics Market Drivers
2.3.3 Respiratory Diagnostics Market Challenges
2.3.4 Respiratory Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Diagnostics Players by Revenue
3.1.1 Global Top Respiratory Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Respiratory Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Respiratory Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Diagnostics Revenue
3.4 Global Respiratory Diagnostics Market Concentration Ratio
3.4.1 Global Respiratory Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Diagnostics Revenue in 2023
3.5 Respiratory Diagnostics Key Players Head office and Area Served
3.6 Key Players Respiratory Diagnostics Product Solution and Service
3.7 Date of Enter into Respiratory Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Diagnostics Breakdown Data by Type
4.1 Global Respiratory Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Respiratory Diagnostics Forecasted Market Size by Type (2025-2030)
5 Respiratory Diagnostics Breakdown Data by Application
5.1 Global Respiratory Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Respiratory Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Respiratory Diagnostics Market Size (2019-2030)
6.2 North America Respiratory Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Respiratory Diagnostics Market Size by Country (2019-2024)
6.4 North America Respiratory Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Respiratory Diagnostics Market Size (2019-2030)
7.2 Europe Respiratory Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Respiratory Diagnostics Market Size by Country (2019-2024)
7.4 Europe Respiratory Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Respiratory Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Respiratory Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Respiratory Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Respiratory Diagnostics Market Size (2019-2030)
9.2 Latin America Respiratory Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Respiratory Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Respiratory Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Respiratory Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Respiratory Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Respiratory Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Philips Healthcare
11.1.1 Philips Healthcare Company Detail
11.1.2 Philips Healthcare Business Overview
11.1.3 Philips Healthcare Respiratory Diagnostics Introduction
11.1.4 Philips Healthcare Revenue in Respiratory Diagnostics Business (2019-2024)
11.1.5 Philips Healthcare Recent Development
11.2 Becton, Dickinson
11.2.1 Becton, Dickinson Company Detail
11.2.2 Becton, Dickinson Business Overview
11.2.3 Becton, Dickinson Respiratory Diagnostics Introduction
11.2.4 Becton, Dickinson Revenue in Respiratory Diagnostics Business (2019-2024)
11.2.5 Becton, Dickinson Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Respiratory Diagnostics Introduction
11.3.4 Abbott Laboratories Revenue in Respiratory Diagnostics Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Respiratory Diagnostics Introduction
11.4.4 Thermo Fisher Scientific Revenue in Respiratory Diagnostics Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Respiratory Diagnostics Introduction
11.5.4 Abbott Revenue in Respiratory Diagnostics Business (2019-2024)
11.5.5 Abbott Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
